Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fleischhacker

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Schizophrenia Research|October 8, 2013
Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?Robin Emsley, Wolfgang W Fleischhacker
Drug Safety|January 27, 2000
Managing antipsychotic-induced acute and chronic akathisiaC H Miller, W W Fleischhacker
Fortschritte Der Neurologie-Psychiatrie|November 5, 2005
[Pathophysiology of schizophrenia and its impact on pharmacotherapy]C G Widschwendter, W W Fleischhacker
International Clinical Psychopharmacology|January 1, 1995
Adverse effects of antipsychotic drugsA B Whitworth, W W Fleischhacker
Drug and Alcohol Dependence|May 1, 1986
The psychopathology of alcoholismW W Fleischhacker, K Kryspin-Exner
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Memantine in the treatment of senile dementia of the Alzheimer typeW W Fleischhacker, A Buchgeher, H Schubert
Fortschritte Der Neurologie-Psychiatrie|September 1, 1993
[Clozapine in long-term treatment of schizophrenic patients]U Meise, M Kurz, W W Fleischhacker
Pharmacopsychiatry|May 1, 1989
Benzodiazepines: utilization and patterns of use in a university hospitalW W Fleischhacker, C Barnas, C Stuppäck
Schizophrenia Bulletin|January 1, 1994
Antipsychotic maintenance treatment of schizophrenia patients: is there a consensus?U Meise, M Kurz, W W Fleischhacker
Wiener Medizinische Wochenschrift (1946)|September 25, 1998
[Compliance problems in treatment of schizophrenic patients]C Barnas, M Hummer, W W Fleischhacker
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Schizophrenia Research|October 8, 2013
Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?Robin Emsley, Wolfgang W Fleischhacker
Drug Safety|January 27, 2000
Managing antipsychotic-induced acute and chronic akathisiaC H Miller, W W Fleischhacker
Fortschritte Der Neurologie-Psychiatrie|November 5, 2005
[Pathophysiology of schizophrenia and its impact on pharmacotherapy]C G Widschwendter, W W Fleischhacker
International Clinical Psychopharmacology|January 1, 1995
Adverse effects of antipsychotic drugsA B Whitworth, W W Fleischhacker
Drug and Alcohol Dependence|May 1, 1986
The psychopathology of alcoholismW W Fleischhacker, K Kryspin-Exner
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Memantine in the treatment of senile dementia of the Alzheimer typeW W Fleischhacker, A Buchgeher, H Schubert
Fortschritte Der Neurologie-Psychiatrie|September 1, 1993
[Clozapine in long-term treatment of schizophrenic patients]U Meise, M Kurz, W W Fleischhacker
Pharmacopsychiatry|May 1, 1989
Benzodiazepines: utilization and patterns of use in a university hospitalW W Fleischhacker, C Barnas, C Stuppäck
Schizophrenia Bulletin|January 1, 1994
Antipsychotic maintenance treatment of schizophrenia patients: is there a consensus?U Meise, M Kurz, W W Fleischhacker
Wiener Medizinische Wochenschrift (1946)|September 25, 1998
[Compliance problems in treatment of schizophrenic patients]C Barnas, M Hummer, W W Fleischhacker
Pageof 15